This is a preview of subscription content, log in via an institution to check access.
REFERENCES
S. S. Sergeeva, D. Deleva, É. Zapryanova, “Responses of Retzius neurons in the leech to synaptic activation at different frequencies during exposure to antiserum to gangliosides,” Dokl. Akad. Nauk, 362,No. 2, 280–282 (1998).
S. S. Sergeeva, O. S. Sotnikov, D. Deleva, et al., “The actions of antibodies to gangliosides on electrogenesis and Na channel activity in membranes of leech visceral neurons,” in: Proceedings of the International Conference Celebrating the 150th Anniversary of I. P. Pavlov, “Mechanisms of Function of Visceral System” [in Russian], I. P. Pavlov Institute of Physiology Press, Russian Academy of Sciences, St. Petersburg (1999), pp. 341–342.
O. S. Sotnikov, Functional Morphology of Living Tissue Nerve Fibers [in Russian], Nauka, Leningrad (1976).
E. Alvord, M. Kies, and A. Sucking, “Useful model for multiple sclerosis,” in: Experimental Allergic Encephalomyelitis, Academic Press, New York (1984).
M. Christova-Grekova, M. Svetoslavova, E. Zaprianova, et al., “Effect of exogenic brain gangliosides in the CNS-clinical and immunological data,” Compt. Rend. Acad. Sci. Bulg., 41, 145–147 (1988).
D. Collins and G. Francis, “Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions,” Ann. Neurol., 41, 385–391 (1997).
R. J. Cotello and U. Pott, “Signals that initiate myelination in the developing mammalian nervous system,” Mol. Neurobiol., 15,No. 1, 83–100 (1997).
G. de Vries and W. Norton, “The lipid composition of axons from bovine brain,” J. Neurochem., 22, 259–264 (1974).
J. P. Doyle and D. R. Colman, “Glial-neuron interactions and the regulation of myelin formation,” Curr. Opin. Cell. Biol., 5, 779–785 (1993).
J. Heley and R. Ledeen, “Incorporation of axonally transported substances into myelin lipids,” J. Neurochem., 32, 735–742 (1979).
G. L. Kidd, P. E. Hauer, and B. D. Trapp, “Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo,” J. Neurosci., 26, 409–418 (1990).
H. Lassmann, K. Kitz, and H. Wisniewski, “Structural variability of demyelinating lesion in different models of subacute and chronic experimental allergic encephalomyelitis,” Acta Neuropathol. (Bel.), 51, 191–201 (1980).
C. S. Raine, “Biology of disease — analysis of autoimmune demyelination: its impact upon multiple sclerosis,” Lab. Invest., 50, 608–635 (1984).
B. D. Trapp, P. Hauer, and G. Kemke, “Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells,” J. Neurosci., 8,No. 9, 3515–3521 (1988).
B. Trapp, J. Peterson, R. Ransohoff, et al., “Axonal transection in the lesions of multiple sclerosis,” New Engl. J. Med., 338, 278–285 (1998).
S. Waxman, “Multiple sclerosis as a neuronal disease,” Arch. Neurol., 57, 22–24 (2000).
R. Yu, and R. Igbal, “Sialosylgalactosyl ceramide as a specific marker for human myelin and oligodendroglial perikarya: gangliosides of human myelin, oligodendroglia and neurons,” J. Neurochem., 32, 293–300 (1979).
E. Zaprianova, “Histochemistry and morphological metabolism of lipids in the chicken brain in relation to myelination,” Acta Anat., 75, 267–300 (1970).
E. Zaprianova, “The activity of the nerve cells at the time of myelination in the central nervous system,” in: Proc. VII. International Congr. Neuropathol., Excerpta Medica, Amsterdam (1975), pp. 729–732.
E. Zaprianova, Myelination in the Central Nervous System, Bulgarian Academy of Sciences Press, Sofia (1980), p. 124.
E. Zaprianova, “Central nervous system myelin sheath,” in: Abstr. Regional South-East Europ. Conf. Neurol. Psych., Varna (1984), p. 107.
E. Zaprianova, “Neuronal-glial interactions during production of myelin phospholipids,” Neuropathol. Applied Neurobiol., 22,Suppl. 1, 32–33 (1996).
E. Zaprianova, D. Deleva, and A. Filchev, “Ganglioside changes in brain in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat,” Neurochem. Res., 23,No. 11, 1421–1425 (1998).
E. Zaprianova, D. Deleva, P. Ilinov, et al., “Serum ganglioside patterns in multiple sclerosis,” Neurochem. Res., 26,No. 2, 95–100 (2001).
F. Zipp, P. H. Krammer, and M. Weller, “Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system,” Immunol. Today, 20,No. 12, 550–554 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zapryanova, É., Sotnikov, O.S., Sergeeva, S.S. et al. Axon Reactions Precede Demyelination in Experimental Models of Multiple Sclerosis. Neurosci Behav Physiol 34, 337–342 (2004). https://doi.org/10.1023/B:NEAB.0000018743.05208.23
Issue Date:
DOI: https://doi.org/10.1023/B:NEAB.0000018743.05208.23